Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
fever	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Percutaneous	O
cholangiogram	O
Biliary	O
drain	O
adjustment	O
History	O
of	O
Present	O
Illness:	O
___	O
year	O
old	O
male	O
with	O
metastatic	O
pancreatic	O
adenocarcinoma	O
(to	O
the	O
liver	O
and	O
lung)	O
who	O
presented	O
to	O
the	O
clinic	O
today	O
for	O
C2D1	O
of	O
FOLFOX	O
and	O
was	O
found	O
to	O
have	O
a	O
fever	O
of	O
___.	O
He	O
is	O
sent	O
in	O
for	O
work-up	O
and	O
management	O
of	O
fever.	O
Review	O
of	O
the	O
OMR	O
shows	O
recent	O
admission	O
___	O
for	O
pulmonary	O
edema	O
and	O
anasarca	O
that	O
was	O
felt	O
to	O
be	O
secondary	O
to	O
non-cardiogenic	O
edema.	O
TTE	O
revealed	O
preserved	O
EF	O
and	O
moderate	O
MR	O
___	O
responded	O
well	O
to	O
diuresis	O
and	O
was	O
discharged	O
on	O
bid	O
Lasix.	O
The	O
___	O
and	O
his	O
daughter	O
provide	O
the	O
history.	O
He	O
has	O
been	O
having	O
low	O
grade	O
temperatures	O
of	O
about	O
___	O
for	O
the	O
past	O
week	O
and	O
the	O
day	O
prior	O
to	O
presentation	O
had	O
a	O
temperature	O
of	O
___.	O
His	O
daughter	O
reports	O
he	O
was	O
also	O
extremely	O
weak	O
starting	O
the	O
day	O
prior	O
to	O
presentation	O
and	O
had	O
trouble	O
dressing	O
himself.	O
In	O
clinic	O
today	O
during	O
his	O
visit	O
to	O
Dr.	O
___	O
also	O
had	O
a	O
fever	O
of	O
___	O
and	O
was	O
noted	O
to	O
lethargic.	O
He	O
has	O
had	O
no	O
shaking	O
chills.	O
Review	O
of	O
systems	O
is	O
notable	O
for	O
approximately	O
two	O
episodes	O
of	O
diarrhea	O
daily	O
in	O
the	O
past	O
week	O
without	O
abdominal	O
pain.	O
No	O
nausea	O
or	O
vomiting.	O
The	O
diarrhea	O
is	O
said	O
to	O
be	O
greenish	O
and	O
foul	O
smelling.	O
The	O
___	O
denied	O
in	O
changes	O
in	O
his	O
urine,	O
but	O
per	O
nursing	O
the	O
urine	O
is	O
a	O
dark	O
brown	O
color.	O
Recent	O
history	O
is	O
notable	O
for	O
fever	O
some	O
weeks	O
ago	O
while	O
the	O
___	O
was	O
on	O
the	O
___	O
and	O
at	O
that	O
time	O
he	O
was	O
treated	O
empirically	O
with	O
Levaquin;	O
it	O
seems	O
there	O
was	O
some	O
suspicion	O
for	O
pneumonia.	B-Lower_respiratory_tract_infection
However,	O
the	O
___	O
denies	O
SOB	O
or	O
cough	O
or	O
URI	O
symptoms.	O
Past	O
Medical	O
History:	O
PAST	O
ONCOLOGIC	O
HISTORY:	O
Mr.	O
___	O
underwent	O
Whipple's	O
pancreaticoduodenectomy	O
___	O
for	O
resection	O
of	O
a	O
3.9cm	O
moderately	O
differentiated	O
adenocarcinoma.	O
___	O
lymph	O
nodes	O
were	O
involved;	O
margins	O
negative,	O
LVI	O
and	O
perineural	O
invasion	O
present.	O
He	O
was	O
diagnosed	O
with	O
pT3N1	O
stage	O
IIB	O
PDA.	O
He	O
received	O
six	O
months	O
adjuvant	O
gemcitabine	O
and	O
chemoradiation.	O
Liver	O
metastasis	O
was	O
confirmed	O
on	O
biopsy	O
___,	O
and	O
he	O
initiated	O
treatment	O
on	O
clinical	O
trial	O
___.	O
He	O
completed	O
eight	O
cycles	O
as	O
of	O
___	O
at	O
which	O
time	O
there	O
was	O
disease	O
progression	O
in	O
the	O
liver	O
and	O
lung,	O
and	O
he	O
transitioned	O
to	O
second	O
line	O
therapy	O
with	O
FOLFOX.	O
PAST	O
MEDICAL	O
HISTORY:	O
-atrial	O
fibrillation:	O
s/p	O
cardioversion	O
attempts	O
in	O
___.	O
-Hypertension	O
-Hyperlipidemia	O
-gastritis	O
on	O
whipple	O
resection	O
specimen	O
___	O
-pancreatic	O
cancer	O
as	O
above	O
Social	O
History:	O
___	O
Family	O
History:	O
brother	O
with	O
lung	O
cancer,	O
no	O
history	O
GI	O
cancer	O
Physical	O
Exam:	O
ADMISSION	O
EXAM:	O
General:	O
NAD	O
VITAL	O
SIGNS:	O
T	O
99	O
BP	O
103/50	O
HR	O
96	O
RR	O
18	O
SpO2	O
96%	O
RA	O
HEENT:	O
NC/AT,	O
anicteric,	O
MMM,	O
no	O
OP	O
lesions,	O
no	O
cervical,	O
supraclavicular,	O
or	O
axillary	O
adenopathy	O
CV:	O
irregularly	O
irregular,	O
nl	O
S1S2,	O
murmurs	O
not	O
appreciated	O
PULM:	O
moving	O
air	O
well,	O
right	O
base	O
crackles,	O
?	O
decrease	O
in	O
breath	O
sounds	O
at	O
the	O
left	O
base,	O
no	O
wheezing	O
ABD:	O
BS+,	O
flat,	O
soft,	O
NTND,	O
no	O
masses	O
or	O
hepatosplenomegaly	O
LIMBS:	O
trace	O
bilateral	O
pedal	O
edema	O
SKIN:	O
No	O
rashes	O
or	O
skin	O
breakdown	O
observed	O
NEURO:	O
oriented	B-Delirium
to	O
self,	O
date	O
and	O
place,	O
CN	O
II-XII	O
intact	O
(vision	O
was	O
not	O
tested	O
in	O
detail),	O
appears	O
to	O
have	O
normal	O
speech	O
mostly	O
in	O
___	O
and	O
normal	O
comprehension,	O
strength	O
is	O
___	O
in	O
the	O
upper	O
and	O
lower	O
extremities	O
proximally	O
and	O
distally,	O
no	O
pronator	O
drift	O
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
___	O
08:45AM	O
BLOOD	O
WBC-5.5	O
RBC-3.47*	O
Hgb-7.8*	O
Hct-27.4*	O
MCV-79*	O
MCH-22.5*	O
MCHC-28.5*	O
RDW-21.4*	O
RDWSD-59.1*	O
Plt	O
___	O
___	O
08:45AM	O
BLOOD	O
UreaN-9	O
Creat-0.7	O
Na-133	O
K-3.1*	O
Cl-95*	O
HCO3-27	O
AnGap-14	O
___	O
08:45AM	O
BLOOD	O
ALT-38	O
AST-62*	O
AlkPhos-407*	O
TotBili-2.8*	O
DirBili-2.1*	O
IndBili-0.7	O
___	O
08:45AM	O
BLOOD	O
Albumin-2.9*	O
Calcium-7.9*	O
Mg-2.1	O
IMAGING:	O
Portable	O
CXR	O
___:	O
As	O
compared	O
to	O
___	O
radiograph,	O
lung	O
volumes	O
are	O
lower	O
with	O
associated	O
accentuation	O
of	O
cardiomediastinal	O
contours	O
in	O
crowding	O
of	O
bronchovascular	O
structures.	O
New	O
bibasilar	O
patchy	O
opacities	O
have	O
developed,	O
left	O
greater	O
than	O
right,	O
which	O
could	O
potentially	O
be	O
due	O
to	O
developing	O
pneumonia	B-Lower_respiratory_tract_infection
in	O
the	O
appropriate	O
clinical	O
setting,	O
particularly	O
at	O
the	O
left	O
base.	O
Aspiration	O
is	O
an	O
additional	O
consideration.	O
Exam	O
is	O
otherwise	O
remarkable	O
for	O
small	O
left	O
pleural	O
effusion	O
and	O
linear	O
atelectasis	O
in	O
the	O
right	O
lower	O
lobe.	O
MRCP	O
___	O
IMPRESSION:	O
1.	O
Interval	O
increase	O
in	O
the	O
size	O
of	O
an	O
ill-defined	O
hilar	O
metastasis	O
in	O
segment	O
4A/B	O
resulting	O
in	O
biliary	O
obstruction,	O
and	O
upstream	O
dilatation	O
of	O
the	O
intrahepatic	O
biliary	O
ducts.	O
The	O
biliary	O
enteric	O
anastomosis	O
is	O
not	O
well	O
seen.	O
2.	O
Interval	O
worsening	O
of	O
multiple	O
metastatic	O
lesions	O
within	O
the	O
liver,	O
predominating	O
in	O
segments	O
4A,	O
4B,	O
and	O
5.	O
3.	O
Superimposed	O
inflammatory	O
cholangitis	O
in	O
the	O
central	O
liver.	O
___	O
PTC	O
FINDINGS:	O
Mild	O
to	O
moderately	O
dilated	O
right	O
biliary	O
tree.	O
Successful	O
placement	O
of	O
an	O
8	O
___	O
modified	O
8	O
APD	O
internal/external	O
catheter	O
through	O
the	O
biliary	O
system	O
and	O
into	O
the	O
small	O
bowel.	O
___	O
catheter	O
check	O
IMPRESSION:	O
Successful	O
exchange,	O
repositioning	O
and	O
upsize	O
to	O
a	O
right	O
___	O
internal-external	O
biliary	O
drain.	O
RECOMMENDATION(S):	O
Keep	O
to	O
bag	O
drainage,	O
and	O
consider	O
capping	O
trial	O
tomorrow.	O
IMPRESSION:	O
Preliminary	O
Report1.	O
Interval	O
improvement	O
in	O
the	O
biliary	O
duct	O
dilation	O
in	O
the	O
segment	O
of	O
the	O
Preliminary	O
Reportright	O
lobe	O
of	O
the	O
liver	O
which	O
is	O
being	O
drained	O
by	O
the	O
PTBD.	O
The	O
biliary	O
Preliminary	O
Reportdilation	O
in	O
the	O
remainder	O
of	O
the	O
liver	O
has	O
slightly	O
worsened,	O
as	O
described	O
Preliminary	O
Reportabove.	O
The	O
post-contrast	O
images	O
are	O
limited	O
by	O
the	O
timing	O
of	O
the	O
contrast	O
Preliminary	O
Reportbolus	O
and	O
motion,	O
though	O
there	O
is	O
no	O
definite	O
active	O
cholangitis.	O
Preliminary	O
Report2.	O
The	O
known	O
hepatic	O
metastases	O
are	O
not	O
significantly	O
changed.	O
Due	O
to	O
the	O
Preliminary	O
Reportpatient's	O
inability	O
to	O
breath	O
hold	O
and	O
remain	O
still	O
for	O
an	O
MRI,	O
consider	O
using	O
Preliminary	O
ReportCT	O
for	O
future	O
follow-up	O
exams.	O
Preliminary	O
Report3.	O
Expected	O
postoperative	O
changes	O
after	O
a	O
Whipple.	O
Preliminary	O
Report4.	O
Mild	O
splenomegaly.	O
Preliminary	O
Report5.	O
Small	O
amount	O
of	O
ascites.	O
Preliminary	O
Report6.	O
Partially	O
imaged	O
unchanged	O
thoracic	O
aortic	O
aneurysm.	O
Preliminary	O
Report7.	O
Small	O
bilateral	O
pleural	O
effusions.	O
Microbiology:	O
___	O
5:20	O
pm	O
BILE	O
**FINAL	O
REPORT	O
___	O
GRAM	O
STAIN	O
(Final	O
___:	O
NO	O
POLYMORPHONUCLEAR	O
LEUKOCYTES	O
SEEN.	O
NO	O
MICROORGANISMS	O
SEEN.	O
FLUID	O
CULTURE	O
(Final	O
___:	O
ENTEROCOCCUS	O
SP..	O
SPARSE	O
GROWTH.	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
_________________________________________________________	O
ENTEROCOCCUS	O
SP.	O
|	O
AMPICILLIN------------	O
<=2	O
S	O
PENICILLIN	O
G----------	O
0.5	O
S	O
VANCOMYCIN------------	O
<=0.5	O
S	O
ANAEROBIC	O
CULTURE	O
(Final	O
___:	O
NO	O
ANAEROBES	O
ISOLATED.	O
___	O
4:30	O
am	O
URINE	O
Source:	O
Catheter.	O
**FINAL	O
REPORT	O
___	O
URINE	O
CULTURE	O
(Final	O
___:	O
NO	O
GROWTH.	O
___	O
9:00	O
am	O
BLOOD	O
CULTURE	O
Source:	O
Line-POC.	O
Blood	O
Culture,	O
Routine	O
(Preliminary):	O
PSEUDOMONAS	O
AERUGINOSA.	O
FINAL	O
SENSITIVITIES.	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
_________________________________________________________	O
PSEUDOMONAS	O
AERUGINOSA	O
|	O
CEFEPIME--------------	O
2	O
S	O
CEFTAZIDIME-----------	O
4	O
S	O
CIPROFLOXACIN---------<=0.25	O
S	O
GENTAMICIN------------	O
<=1	O
S	O
MEROPENEM-------------<=0.25	O
S	O
PIPERACILLIN/TAZO-----	O
8	O
S	O
TOBRAMYCIN------------	O
<=1	O
S	O
___	O
5:30	O
pm	O
BILE	O
RIGHT	O
BILIARY	O
TREE	O
PTBD	O
(BIL	O
CX).	O
**FINAL	O
REPORT	O
___	O
GRAM	O
STAIN	O
(Final	O
___:	O
NO	O
POLYMORPHONUCLEAR	O
LEUKOCYTES	O
SEEN.	O
NO	O
MICROORGANISMS	O
SEEN.	O
FLUID	O
CULTURE	O
(Final	O
___:	O
PSEUDOMONAS	O
AERUGINOSA.	O
SPARSE	O
GROWTH.	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
_________________________________________________________	O
PSEUDOMONAS	O
AERUGINOSA	O
|	O
CEFEPIME--------------	O
<=1	O
S	O
CEFTAZIDIME-----------	O
2	O
S	O
CIPROFLOXACIN---------<=0.25	O
S	O
GENTAMICIN------------	O
<=1	O
S	O
MEROPENEM-------------<=0.25	O
S	O
PIPERACILLIN/TAZO-----	O
8	O
S	O
TOBRAMYCIN------------	O
<=1	O
S	O
Pertinent	O
Labs:	O
___	O
05:46AM	O
BLOOD	O
WBC-6.8	O
RBC-4.17*	O
Hgb-10.1*	O
Hct-34.7*	O
MCV-83	O
MCH-24.2*	O
MCHC-29.1*	O
RDW-24.2*	O
RDWSD-70.5*	O
Plt	O
___	O
___	O
05:38AM	O
BLOOD	O
WBC-13.9*#	O
RBC-4.59*	O
Hgb-11.3*	O
Hct-37.3*	O
MCV-81*	O
MCH-24.6*	O
MCHC-30.3*	O
RDW-24.5*	O
RDWSD-69.7*	O
Plt	O
___	O
___	O
12:35AM	O
BLOOD	O
WBC-39.5*#	O
RBC-4.58*	O
Hgb-11.0*	O
Hct-41.2	O
MCV-90#	O
MCH-24.0*	O
MCHC-26.7*#	O
RDW-23.3*	O
RDWSD-75.9*	O
Plt	O
___	O
___	O
05:49AM	O
BLOOD	O
WBC-28.7*	O
RBC-3.85*	O
Hgb-9.3*	O
Hct-35.9*	O
MCV-93	O
MCH-24.2*	O
MCHC-25.9*	O
RDW-23.5*	O
RDWSD-78.8*	O
Plt	O
___	O
___	O
11:57AM	O
BLOOD	O
___	O
PTT-101.3*	O
___	O
___	O
06:09AM	O
BLOOD	O
Glucose-126*	O
UreaN-8	O
Creat-0.7	O
Na-139	O
K-3.2*	O
Cl-101	O
HCO3-30	O
AnGap-11	O
___	O
11:57AM	O
BLOOD	O
Glucose-138*	O
UreaN-20	O
Creat-2.9*	O
Na-132*	O
K-6.5*	O
Cl-97	O
HCO3-6*	O
AnGap-36*	O
___	O
06:09AM	O
BLOOD	O
ALT-17	O
AST-35	O
AlkPhos-311*	O
TotBili-3.0*	O
DirBili-2.5*	O
IndBili-0.5	O
___	O
05:49AM	O
BLOOD	O
ALT-740*	O
AST-4328*	O
LD(LDH)-4180*	O
AlkPhos-568*	O
TotBili-8.3*	O
___	O
11:04AM	O
BLOOD	O
Type-ART	O
pO2-154*	O
pCO2-23*	O
pH-7.48*	O
calTCO2-18*	O
Base	O
XS--3	O
___	O
11:48AM	O
BLOOD	O
Type-ART	O
Temp-37.8	O
Rates-32/	O
Tidal	O
V-500	O
PEEP-5	O
FiO2-60	O
pO2-98	O
pCO2-23*	O
pH-6.99*	O
calTCO2-6*	O
Base	O
XS--25	O
-ASSIST/CON	O
Intubat-INTUBATED	O
___	O
12:12PM	O
BLOOD	O
Type-ART	O
Temp-37.2	O
pO2-93	O
pCO2-22*	O
pH-7.07*	O
calTCO2-7*	O
Base	O
XS--22	O
Intubat-INTUBATED	O
___	O
11:04AM	O
BLOOD	O
Lactate-6.4*	O
___	O
09:45PM	O
BLOOD	O
Lactate-10.7*	O
___	O
03:37AM	O
BLOOD	O
Lactate-13.6*	O
___	O
07:48AM	O
BLOOD	O
Lactate-13.9*	O
___	O
05:07PM	O
BLOOD	O
Lactate-14.0*	O
___	O
12:12PM	O
BLOOD	O
Lactate-15.5*	O
Brief	O
Hospital	O
Course:	O
___	O
w/	O
Afib	O
s/p	O
DCCV,	O
MR/TR,	O
HTN,	O
DL,	O
COPD	O
and	O
pancreatic	O
adenocarcinoma	O
s/p	O
Whipple	O
(___),	O
s/p	O
adjuvant	O
chemoradiation	O
with	O
liver	O
and	O
lung	O
mets	O
on	O
C1	O
palliative	O
FOLFOX	O
p/w	O
fever	O
and	O
elevated	O
tbili	O
on	O
___	O
and	O
was	O
started	O
on	O
Vanc/ceftriaxone	O
and	O
flagyl,	O
who	O
was	O
found	O
to	O
have	O
c.	O
diff	O
colitis	O
and	O
enterococcus	O
bacteremia	O
and	O
was	O
switched	O
to	O
ampicillin	O
on	O
___	O
based	O
on	O
culture	O
sensitivities.	O
In	O
addition,	O
an	O
MRCP	O
was	O
performed	O
which	O
showed	O
biliary	O
obstruction	O
and	O
on	O
___	O
___	O
placed	O
8	O
___	O
internal/external	O
catheter	O
thru	O
R	O
hepatic	O
duct.	O
There	O
was	O
post-procedure	O
leakage,	O
on	O
___	O
the	O
drain	O
was	O
upsized	O
to	O
a	O
___	O
internal-external	O
biliary	O
drain	O
w/	O
extra	O
side	O
holes.	O
On	O
___	O
the	O
___	O
triggered	O
for	O
a.	O
fib	O
with	O
RVR	O
and	O
altered	B-Delirium
mental	B-Delirium
status.	B-Delirium
Rate	O
control	O
was	O
achieved	O
on	O
the	O
floor,	O
the	O
___	O
was	O
intubated	O
in	O
order	O
to	O
protect	O
his	O
airway	O
and	O
he	O
was	O
brought	O
to	O
the	O
FICU	O
for	O
management	O
of	O
septic	O
shock	O
and	O
his	O
antibiotics	O
were	O
broadened.	O
Later	O
that	O
day,	O
the	O
___	O
went	O
to	O
___	O
to	O
have	O
additional	O
drains	O
placed	O
to	O
relieve	O
his	O
biliary	O
obstruction.	O
Upon	O
returning	O
from	O
the	O
procedure,	O
the	O
___	O
lactate	O
rose	O
from	O
6.4	O
to	O
8.9	O
and	O
developed	O
a	O
profound	O
leukocytosis	O
of	O
39.5.	O
He	O
was	O
given	O
multiple	O
fluid	O
boluses	O
and	O
required	O
3	O
pressors	O
to	O
maintain	O
his	O
blood	O
pressure.	O
The	O
___	O
family	O
was	O
called	O
during	O
the	O
early	O
morning	O
of	O
___	O
and	O
the	O
___	O
was	O
made	O
DNR.	O
After	O
worsening	O
lactates,	O
increased	O
pressor	O
requirements	O
and	O
no	O
clinical	O
improvement	O
during	O
the	O
day,	O
the	O
family	O
decided	O
pursue	O
comfort	O
focused	O
care,	O
after	O
which	O
the	O
___	O
passed	O
away.	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Cetirizine	O
10	O
mg	O
PO	O
DAILY	O
2.	O
Creon	O
___	O
CAP	O
PO	O
TID	O
W/MEALS	O
3.	O
Cyclobenzaprine	O
5	O
mg	O
PO	O
TID:PRN	O
pain/muscle	O
cramps	O
4.	O
Digoxin	O
0.25	O
mg	O
PO	O
DAILY	O
5.	O
Furosemide	O
40	O
mg	O
PO	O
BID	O
6.	O
Metoprolol	O
Succinate	O
XL	O
300	O
mg	O
PO	O
QHS	O
7.	O
Omeprazole	O
20	O
mg	O
PO	O
BID	O
8.	O
OxycoDONE	O
(Immediate	O
Release)	O
5	O
mg	O
PO	O
Q6H:PRN	O
pain	O
9.	O
Enoxaparin	O
Sodium	O
80	O
mg	O
SC	O
Q12H	O
10.	O
Verapamil	O
40	O
mg	O
PO	O
Q24H	O
11.	O
Albuterol	O
Inhaler	O
2	O
PUFF	O
IH	O
Q4H:PRN	O
sob	O
or	O
wheezing	O
12.	O
Levemir	O
(insulin	O
detemir)	O
6	O
units	O
subcutaneous	O
qhs	O
Discharge	O
Medications:	O
n/a	O
Discharge	O
Disposition:	O
Expired	O
Discharge	O
Diagnosis:	O
Primary	O
Diagnosis:	O
Septic	O
Shock	O
Bacteremia	O
Secondary	O
Diagnosis:	O
Metastatic	O
Pancreatic	O
Cancer	O
C.	O
difficle	O
collitis	O
Discharge	O
Condition:	O
___	O
is	O
deceased	O
Discharge	O
Instructions:	O
n/a	O
Followup	O
Instructions:	O
___	O

